Xolair - Biological Therapy for the Treatment of Asthma

Print

Xolair works by binding to free immunoglobulin E (IgE) in the blood to prevent mast cell degranulation and the release of pharmacologically active substances that are the hallmark of the early allergic inflammatory process. (Source: ABPI)
 
«Back | Next»




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development